On this episode of Psychedelic Insiders, Jeeshan Chowdhury, Co-Founder and CEO of Journey CoLab opens up about his intentional path set for the company, using mescaline as medicine to combat endemic addictions like Alcohol Use Disorder. He talks to Jason Najum about drug development, psychedelic mental health care, and more.

PSYCHEDELIC INSIDERS

Each week, we'll be diving deep with psychedelic industry leaders into the startup scene, IPO tracks, the investment landscape, financing rounds, and the operational side of running a high-performance psychedelic company.

LINKS:

Video of interview: https://youtu.be/qq2wCyJ3aCc

www.journeycolab.com

www.microdose.buzz

Subscribe today!

on Apple Podcasts: https://podcasts.apple.com/us/podcast/psychedelic-insiders/id1531628901

on Spotify: https://open.spotify.com/show/3Nyc58Ov7GYBeeLcWheBSx

on Youtube: https://www.youtube.com/playlist?list=PLMj79P4l-kSl5YY6VA9mbkOxQPDrM5NE1